|
About:
|
Bevacizumab additionally erlotinib vs . erlotinib on your own throughout Western patients using advanced, metastatic, EGFR-mutant non-small-cell cancer of the lung (NEJ026): general tactical examination of your open-label, randomised, multicentre, phase Three tryout.
|
